title: [AstraZeneca--Research focus infectious diseases].
authors.affiliation: Geschäftsführer AstraZeneca Deutschland.
authors.forename: D
authors.initials: D
authors.lastname: Greshake
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000627:therapeutic use; D017277:Drug Approval; D004345:Drug Industry; D024881:Drug Resistance, Bacterial; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D057170:Translational Research, Biomedical; D000097583:Ceftaroline
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000097583:Ceftaroline